Related Experiment Video
Updated: May 12, 2026

Spinal Cord Neurons Isolation and Culture from Neonatal Mice
Published on: July 11, 2017
Preservation of motor function after spinal cord ischemia and reperfusion injury through microglial inhibition
Phillip D Smith1, Marshall T Bell, Ferenc Puskas
1Department of Surgery, Division of Cardiothoracic Surgery, University of Colorado, Anschutz Medical Campus, Aurora, CO 80045, USA. phillip.smith@ucdenver.edu
Background:
Paraplegia remains a devastating complication of thoracoabdominal aortic procedures resulting from spinal cord ischemia and reperfusion injury (SCIR). Pharmacologic interventions have not proven efficacious in attenuating this injury, with poor understanding of the underlying mechanisms. The resident macrophages, or microglia in the spinal cord, may play a significant role in SCIR. The macrolide antibiotic, minocycline, has been shown in stroke models to inhibit microglial activation. This study hypothesized that microglial inhibition by minocycline after SCIR will attenuate injury with preservation of motor function.
Methods:
Mature male C57Bl/6 mice underwent 4 minutes of thoracic aortic occlusion with reperfusion. Mice receiving minocycline 30 minutes before ischemia and daily thereafter (90 mg/kg and 45 mg/kg, respectively) were compared with mice receiving vehicle controls. Hind-limb motor function was measured at 12-hour intervals, with spinal cord harvest for histologic and immunologic comparison at 60 hours.
Results:
Minocycline treatment significantly preserved hind limb motor function in all mice (n = 7) compared with complete paralysis in all untreated mice (n = 8), reaching significance from 24 hours of reperfusion through 60 hours. Immunofluorescent staining for Iba-1 revealed significant inhibition of microglial activation by minocycline treatment. Vehicle control sections demonstrated a greater degree of apoptosis compared with minocycline-treated spinal cord sections.
Conclusions:
Minocycline limits microglial activation, paralleling functional preservation after aortic cross-clamping. These data suggest functional microglia contribute to reperfusion injury after spinal cord ischemia. The effects of minocycline demonstrate a potential pharmacological therapy as well as demonstrating a potential cellular target in preventing paraplegia after aortic intervention.
Insights
Minocycline treatment significantly preserved motor function in mice after spinal cord ischemia and reperfusion injury by inhibiting microglial activation. This suggests minocycline as a potential therapy to prevent paralysis following aortic procedures.
Area of Science:
- Neuroscience
- Immunology
- Vascular Surgery
Background:
- Paraplegia is a severe complication of thoracoabdominal aortic procedures, often caused by spinal cord ischemia and reperfusion injury (SCIR).
- Current pharmacologic interventions are ineffective for SCIR, and underlying mechanisms remain poorly understood.
- Microglia, the resident macrophages of the spinal cord, may significantly contribute to SCIR.
Purpose of the Study:
- To investigate the role of microglial activation in SCIR.
- To test the hypothesis that minocycline, an inhibitor of microglial activation, can attenuate SCIR and preserve motor function.
Main Methods:
- Mature male C57Bl/6 mice underwent 4 minutes of thoracic aortic occlusion and reperfusion.
- Minocycline was administered before and daily after ischemia; vehicle controls received no treatment.
- Hind-limb motor function was assessed, and spinal cords were harvested for histological and immunological analysis.
Main Results:
- Minocycline treatment significantly preserved hind-limb motor function compared to complete paralysis in untreated mice.
- Immunofluorescence confirmed minocycline inhibited microglial activation (Iba-1 staining).
- Minocycline-treated spinal cords showed reduced apoptosis compared to controls.
Conclusions:
- Minocycline effectively limits microglial activation, correlating with preserved motor function after aortic cross-clamping.
- These findings indicate that microglia play a functional role in SCIR.
- Minocycline presents a potential pharmacological therapy and a target for preventing paraplegia after aortic interventions.
Related Concept Videos
Secondary Spinal Cord Injury llI: Pathophysiology
Ischemic Stroke ll: Pathophysiology
Neurogenesis and Regeneration of Nervous Tissue
